Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition

被引:253
作者
Braegger, Christian [1 ]
Chmielewska, Anna [1 ]
Decsi, Tamas [2 ]
Kolacek, Sanja [3 ]
Mihatsch, Walter [10 ]
Moreno, Luis [4 ]
Piescik, Malgorzata [1 ]
Puntis, John [5 ]
Shamir, Raanan [6 ]
Szajewska, Hania [7 ]
Turck, Dominique [8 ]
van Goudoever, Johannes [9 ]
机构
[1] Univ Childrens Hosp, Zurich, Switzerland
[2] Univ Pecs, Dept Paediat, Pecs, Hungary
[3] Univ Childrens Hosp, Zagreb, Croatia
[4] Univ Zaragoza, Escuela Univ Ciencias Salud, E-50009 Zaragoza, Spain
[5] Leeds Gen Infirm, Leeds, W Yorkshire, England
[6] Tel Aviv Univ, Sackler Fac Med, Schneider Childrens Med Ctr Israel, Tel Aviv, Israel
[7] Med Univ Warsaw, Dept Paediat, PL-01184 Warsaw, Poland
[8] Univ Lille, Jeanne de Flandre Childrens Hosp, Fac Med, Lille, France
[9] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
[10] Diakonieklinikum, Dept Paediat, Stuttgart, Germany
关键词
feeding; microbiota; modification; paediatric nutrition; 1ST; 6; MONTHS; CHAIN GALACTO-OLIGOSACCHARIDES; MILK FORMULA; BIFIDOBACTERIUM-ANIMALIS; FRUCTO-OLIGOSACCHARIDE; FECAL MICROBIOTA; STREPTOCOCCUS-THERMOPHILUS; ACIDIC OLIGOSACCHARIDES; INTESTINAL MICROFLORA; PRIMARY PREVENTION;
D O I
10.1097/MPG.0b013e3181fb9e80
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Infant formulae are increasingly supplemented with probiotics, prebiotics, or synbiotics despite uncertainties regarding their efficacy. The present article, developed by the Committee on Nutrition of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition, systematically reviews published evidence related to the safety and health effects of the administration of formulae supplemented with probiotics and/or prebiotics compared with unsupplemented formulae. Studies in which probiotics/prebiotics were not administered during the manufacturing process, but thereafter, for example in capsules, the contents of which were supplemented to infant formula or feeds, were excluded. On the basis of this review, available scientific data suggest that the administration of currently evaluated probiotic-and/or prebiotic-supplemented formula to healthy infants does not raise safety concerns with regard to growth and adverse effects. The safety and clinical effects of 1 product should not be extrapolated to other products. At present, there is insufficient data to recommend the routine use of probiotic-and/or prebiotic-supplemented formulae. The Committee considers that the supplementation of formula with probiotics and/or prebiotics is an important field of research. There is a need in this field for well-designed and carefully conducted randomised controlled trials, with relevant inclusion/exclusion criteria and adequate sample sizes. These studies should use validated clinical outcome measures to assess the effects of probiotic and/or prebiotic supplementation of formulae. Such trials should also define the optimal doses and intake durations, as well as provide more information about the long-term safety of probiotics and/or prebiotics. Because most of the trials were company funded, independent trials, preferentially financed jointly by national/governmental/European Union bodies and other international organisations, would be desirable.
引用
收藏
页码:238 / 250
页数:13
相关论文
共 57 条
  • [1] Prebiotic oligosaccharides in dietetic products for infants: A commentary by the ESPGHAN committee on nutrition
    Agostoni, C
    Axelsson, T
    Goulet, O
    Koletzko, B
    Michaelsen, KF
    Puntis, JWL
    Rigo, J
    Shamir, R
    Szajewska, H
    Turck, D
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 39 (05) : 465 - 473
  • [2] Probiotic bacteria in dietetic products for infants: A commentary by the ESPGHAN Committee on Nutrition
    Agostoni, C
    Axelsson, I
    Braegger, C
    Goulet, O
    Koletzko, B
    Michaelsen, KF
    Rigo, J
    Shamir, R
    Szajewska, H
    Turck, D
    Weaver, LT
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 38 (04) : 365 - 374
  • [3] Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels
    Alliet, Philippe
    Scholtens, Petra
    Raes, Marc
    Hensen, Karen
    Jongen, Hanne
    Rummens, Jean-Luc
    Boehm, Guenther
    Vandenplas, Yvan
    [J]. NUTRITION, 2007, 23 (10) : 719 - 723
  • [4] [Anonymous], EFSA J
  • [5] Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life
    Arslanoglu, Sertac
    Moro, Guido E.
    Schmitt, Joachim
    Tandoi, Laura
    Rizzardi, Silvia
    Boehm, Gunther
    [J]. JOURNAL OF NUTRITION, 2008, 138 (06) : 1091 - 1095
  • [6] Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life
    Arslanoglu, Sertac
    Moro, Guido E.
    Boehm, Gunther
    [J]. JOURNAL OF NUTRITION, 2007, 137 (11) : 2420 - 2424
  • [7] Faecal SIgA secretion in infants fed on pre- or probiotic infant formula
    Bakker-Zierikzee, AM
    van Tol, EAF
    Kroes, H
    Alles, MS
    Kok, FJ
    Bindels, JG
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (02) : 134 - 140
  • [8] Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life
    Bakker-Zierikzee, AM
    Alles, MS
    Knol, J
    Kok, FJ
    Tolboom, JJM
    Bindels, JG
    [J]. BRITISH JOURNAL OF NUTRITION, 2005, 94 (05) : 783 - 790
  • [9] BAKKERZIERIKZEE AM, 2005, J PEDIAT GASTROENTER, V40, P639
  • [10] Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli
    Ben, Xiao-Ming
    Li, Juan
    Feng, Zong-Tai
    Shi, Sheng-Yun
    Lu, Ya-Dong
    Chen, Rui
    Zhou, Xiao-Yu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (42) : 6564 - 6568